[Pulmonary embolism: what happens to the emboligenic focus?].
D000328:Adult; D000368:Aged; D004452:Echocardiography; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010690:Phlebography; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Embolie pulmonaire: que devient le foyer emboligène?